Repare Therapeutics Inc. (RPTX) Misses Q1 EPS by 2c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q1 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81). Revenue for the quarter came in at $5.67 million versus the consensus estimate of $5.14 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'